BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30270520)

  • 1. The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma.
    Wang L; Li W; Li K; Guo Y; Liu D; Yao Z; Lin X; Li S; Jiang Z; Liu Q; Jiang Y; Zhang B; Chen L; Zhou F; Ren H; Lin D; Zhang D; Yeung SJ; Zhang H
    Cancer Med; 2018 Oct; 7(10):5205-5216. PubMed ID: 30270520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
    Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
    Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ-TTC17 Promotes Proliferation and Migration of Esophageal Squamous Cell Carcinoma.
    Wang Q; Zhang Q; Sun H; Tang W; Yang L; Xu Z; Liu Z; Jin H; Cao X
    Dig Dis Sci; 2019 Mar; 64(3):751-758. PubMed ID: 30519852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
    Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G
    J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
    Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration.
    Xiao J; Yang W; Xu B; Zhu H; Zou J; Su C; Rong J; Wang T; Chen Z
    BMC Cancer; 2018 Oct; 18(1):976. PubMed ID: 30314454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma.
    Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRRC8A Expression Influences Growth of Esophageal Squamous Cell Carcinoma.
    Konishi T; Shiozaki A; Kosuga T; Kudou M; Shoda K; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Marunaka Y; Otsuji E
    Am J Pathol; 2019 Oct; 189(10):1973-1985. PubMed ID: 31323188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of U three protein 14a (UTP14a) is associated with poor prognosis of esophageal squamous cell carcinoma.
    Li KK; Mao CY; Zhang JG; Ma Q; Wang YJ; Liu XH; Bao T; Guo W
    Thorac Cancer; 2019 Nov; 10(11):2071-2080. PubMed ID: 31496055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAM134B promotes esophageal squamous cell carcinoma in vitro and its correlations with clinicopathologic features.
    Islam F; Gopalan V; Law S; Tang JC; Lam AK
    Hum Pathol; 2019 May; 87():1-10. PubMed ID: 30794892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma.
    Qian Z; Wei B; Zhou Y; Wang Q; Wang J; Sun Y; Gao Y; Chen X
    BMC Cancer; 2019 Jun; 19(1):585. PubMed ID: 31200670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6.
    Liu C; Tian X; Sun HB; Wang ZF; Jiang LF; Li ZX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1069-1076. PubMed ID: 30779074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoplasmic reticulum-localized ECM1b suppresses tumor growth and regulates MYC and MTORC1 through modulating MTORC2 activation in esophageal squamous cell carcinoma.
    Yu VZ; Ko JMY; Ning L; Dai W; Law S; Lung ML
    Cancer Lett; 2019 Oct; 461():56-64. PubMed ID: 31319137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
    Du F; Guo T; Cao C
    Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical Prognostic Value of LRG1 in Esophageal Squamous Cell Carcinoma.
    Wang Y; Xing Q; Chen X; Wang J; Guan S; Chen X; Sun P; Wang M; Cheng Y
    Curr Cancer Drug Targets; 2019; 19(9):756-763. PubMed ID: 30714525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and Malignant Potential of B4GALNT4 in Esophageal Squamous Cell Carcinoma.
    Baba H; Kanda M; Sato Y; Sawaki K; Shimizu D; Koike M; Motoyama S; Kodera Y; Fujii T
    Ann Surg Oncol; 2020 Sep; 27(9):3247-3256. PubMed ID: 32253672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Clinical Six-Flavoprotein-Gene Signature Predicts Prognosis in Esophageal Squamous Cell Carcinoma.
    Peng L; Guo JC; Long L; Pan F; Zhao JM; Xu LY; Li EM
    Biomed Res Int; 2019; 2019():3869825. PubMed ID: 31815134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of SRC-3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness.
    Xu FP; Liu YH; Luo XL; Zhang F; Zhou HY; Ge Y; Liu C; Chen J; Luo DL; Yan LX; Mei P; Xu J; Zhuang HG
    Cancer Med; 2016 Dec; 5(12):3500-3511. PubMed ID: 27781415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
    Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
    Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer.
    Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2646-2652. PubMed ID: 29771416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.